# Better Therapeutics, Inc. (BTTX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BTTX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2023 | $ 0 | $ -24.66M | $ -22.46M | $ 14.31M | $ -9.94M |
| 2022 | $ 0 | $ -44.77M | $ -33.64M | $ 14.88M | $ -899.0K |
| 2021 | $ 337.6K | $ -33.42M | $ -37.32M | $ 9.51M | $ 36.72M |
| 2020 | $ 5.1K | $ -1.35M | $ -7.38M | $ 0 | $ -6.8K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -1.44 |
| Liabilities / Eq | -2.08 |
| Current Ratio | 0.57 |

## Other views

- [Metrics](https://sponda.capital/en/BTTX.md)
- [Charts](https://sponda.capital/en/BTTX/charts.md)
- [Compare](https://sponda.capital/en/BTTX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.
